John H Griffin

This inventor holds 56 USPTO granted patents and 9 published patent applications, plus 5 CIPO patents and 8 EPO patents, primarily in Biomedical Innovations. Top assignees: Scripps Research Institute, Theravance, Inc., Advanced Medicine, Inc.. Active years: 1992-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John H Griffin. Retrieved from https://idiyas.com/inventor/john-h-griffin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 56 (Patent Applications = 9)

% Patents Active = 82.1

CIPO Patents = 5 (Patent Applications = 45)

EPO Patents = 8 (Patent Applications = 7)

Average Co-Inventor Count = 2.5

ph-index = 14

Forward Citations = 620(Granted Patents)

Forward Citations (Not Self Cited) = 601(Dec 10, 2025)

Location History:

San Diego, CA (US) (1992 - 1994)
Fort Lauderdale, FL (US) (2006)
Atherton, CA (US) (2001 - 2009)
Hope Mills, NC (US) (2003 - 2009)
Del Mar, CA (US) (1994 - 2019)

Company Filing History:

20 out of 1,209

Scripps Research Institute

Advanced Medicine, Inc.

patents

4. 4 out of 16,082

University of California

Scripps Clinic and Research Foundation

University of Rochester

patents

9. 4 out of 834,708

Other

patents

where one patent can have more than one assignee

Years Active: 1992-2019

Loading Chart...

Areas of Expertise:

Protease Activated Receptor-1

Cytoprotective Polypeptides

Protein Kinase Inhibitors

Neuroprotective Therapies

Multivalent Macrolide Antibiotics

Oncokinase Fusion Polypeptides

Calcium Channel Drugs

Antibacterial Agents

Muscarinic Receptor Antagonists

Indolinone Derivatives

Activated Protein C

Sodium Channel Drugs

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10407488 - Therapy for treatment or prevention of conditions associated with bleeding or hypocoagulation (2019-09-10),

2. 10273279 - Protease activated receptor-1 (PAR1) derived cytoprotective polypeptides and related methods (2019-04-30),

3. 9605046 - Protease Activated Receptor-1 (PAR1) Derived Cytoprotective Polypeptides and Related Methods (2017-03-28),

4. 9192657 - Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity (2015-11-24),

5. 8445225 - Methods for the detection of circulating tumor cells (2013-05-21),

6. 7968515 - Protein S protects the nervous system from injury (2011-06-28),

7. 7928199 - Stabilized proteins with engineered disulfide bonds (2011-04-19),

8. 7604944 - Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same (2009-10-20),

9. 7603791 - Conditioning apparatus (2009-10-20),

10. 7585653 - Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same (2009-09-08),

11. 7498305 - Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity (2009-03-03),

12. 7456203 - Muscarinic receptor antagonists (2008-11-25),

13. 7223783 - Indolinone derivatives (2007-05-29),

14. 7205278 - Stabilized proteins with engineered disulfide bonds (2007-04-17),

15. 7199126 - Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase (2007-04-03),

Title: The Innovative Journey of John H Griffin

Introduction: John H Griffin, a visionary inventor based in Atherton, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: John H Griffin's latest patents include a cutting-edge virtual reality device that revolutionizes the gaming industry, a patented algorithm for efficient data encryption, and a solar-powered transportation system for sustainable urban mobility.

Career Highlights: Throughout his illustrious career, John H Griffin has been at the forefront of innovation, holding numerous patents in various technological domains. His inventions have not only improved efficiency in industries but have also enhanced the quality of life for many individuals worldwide.

Collaborations: John H Griffin has collaborated with leading tech companies, research institutions, and universities to further develop his inventions and bring them to the market. His collaborative efforts have resulted in groundbreaking solutions that have set new standards in the industry.

Conclusion: John H Griffin's relentless pursuit of innovation and his passion for creating cutting-edge technologies have solidified his reputation as a pioneering inventor in the tech world. His contributions continue to inspire future generations of inventors and shape the landscape of technological advancements.

Profile summary based on public USPTO records.